Clinical Trial Update: Role of Exenatide in NASH-a Pilot Study [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update showing a pilot Phase 2/3 study of exenatide in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Results were posted in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• EXENATIDE (EXENATIDE)

Snippet

Sponsor: Indiana University | Conditions: Nonalcoholic Fatty Liver Disease | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2016-05-12